AbbVie Is a Stock to Position for 2021
Let's review the charts and indicators.
McKesson's Charts Still Look Bullish
Let's review the charts and indicators.
The Correction in AstraZeneca Could Be Nearing an End
Aggressive traders might want to look past any near-term price weakness and consider a small long position.
Concert Pharmaceuticals Could Rally in 2021
Let's review the charts and indicators.
Acceleron Pharma Looks Poised to Continue Bull Run in 2021
The biopharma company's stock has built a nice base, which suggests the shares could keep moving significantly higher in the coming months.
I Like Peloton to Keep Rolling in 2021, and Planet Fitness Might Be a Buy, Too
The former name is technically overbought but offers reasons to expect it to grow, while the latter should benefit from the Covid-19 vaccines.
Let's Put COMPASS Pathways in the Watch but Not Act Yet Category
CMPS may be a company representing the true cannabis 2.0. The irony in that is it isn't a cannabis company but rather a play on psilocybin.
A Technical Update on Halozyme Therapeutics
Let's review the charts and indicators.
McKesson's Rally Has Further to Go
The shares have been digesting and consolidating the gains achieved in early November.
What the Charts Say About Veeva Systems Stock
Our latest analysis and trading strategy for the cloud healthcare software provider.